reAlpha Tech Corp. - Common Stock (NQ:AIRE)
0.3049
-0.0208
(-6.39%)
Streaming Delayed Price
Updated: 11:26 AM EST, Feb 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,033,140 |
| Open | 0.3270 |
| Bid (Size) | 0.3033 (5,500) |
| Ask (Size) | 0.3065 (1,100) |
| Prev. Close | 0.3257 |
| Today's Range | 0.3026 - 0.3299 |
| 52wk Range | 0.1400 - 2.080 |
| Shares Outstanding | 83,765,039 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Which stocks are moving after the closing bell on Tuesday? ↗
December 23, 2025
Top movers in Tuesday's pre-market session ↗
December 23, 2025
Monday's after hours session: top gainers and losers ↗
December 22, 2025
Here are the top movers in Friday's session. ↗
October 24, 2025
Frequently Asked Questions
Is reAlpha Tech Corp. - Common Stock publicly traded?
Yes, reAlpha Tech Corp. - Common Stock is publicly traded.
What exchange does reAlpha Tech Corp. - Common Stock trade on?
reAlpha Tech Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for reAlpha Tech Corp. - Common Stock?
The ticker symbol for reAlpha Tech Corp. - Common Stock is AIRE on the Nasdaq Stock Market
What is the current price of reAlpha Tech Corp. - Common Stock?
The current price of reAlpha Tech Corp. - Common Stock is 0.3049
When was reAlpha Tech Corp. - Common Stock last traded?
The last trade of reAlpha Tech Corp. - Common Stock was at 02/12/26 11:26 AM ET
What is the market capitalization of reAlpha Tech Corp. - Common Stock?
The market capitalization of reAlpha Tech Corp. - Common Stock is 25.54M
How many shares of reAlpha Tech Corp. - Common Stock are outstanding?
reAlpha Tech Corp. - Common Stock has 26M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.